FLORIDA BOARD OF PHARMACY NUCLEAR
PHARMACIST CERTIFICATION EXAM WITH
ACTUAL QUESTIONS AND VERIFIED
ANSWERS, PLUS EXPLAINED
RATIONALES/EXPERT VERIFIED FOR
GUARANTEED 100% PASS 2026/LATEST
UPDATE/INSTANT DOWNLOAD PDF
1. A nuclear pharmacist is preparing a patient-specific unit dose of a
radiopharmaceutical. Which characteristic most directly
distinguishes nuclear pharmacy practice from conventional
pharmacy practice?
A. All medications must be administered intravenously
B. Radiopharmaceuticals require consideration of radioactive decay,
radiation exposure, and radiochemical purity in addition to conventional
medication-related concerns
C. Nuclear pharmacists do not need to verify medication identity
D. Radiopharmaceuticals are exempt from quality-control procedures
Answer: B. Radiopharmaceuticals require consideration of
radioactive decay, radiation exposure, and radiochemical purity in
addition to conventional medication-related concerns
Rationale: Nuclear pharmacy requires the pharmacist to integrate
conventional pharmaceutical principles with radiation safety,
radionuclide identity, physical decay, radiochemical purity, chemical
purity, sterility when applicable, and appropriate handling and
dispensing procedures. The radioactive nature of the product
introduces time-dependent changes and occupational exposure
considerations that do not generally apply to conventional
medications.
1
,2. A technetium-99m preparation has a physical half-life of
approximately 6 hours. If a sample initially contains 80 mCi,
approximately how much activity remains after 18 hours, assuming
no biological elimination?
A. 40 mCi
B. 20 mCi
C. 10 mCi
D. 5 mCi
Answer: C. 10 mCi
Rationale: Eighteen hours represents three physical half-lives. After
one half-life, 80 mCi becomes 40 mCi; after two, 20 mCi; after three,
10 mCi. Thus, the remaining activity is approximately 10 mCi. This
calculation is fundamental when determining expected activity at a
future administration time.
3. Which equation most accurately describes radioactive decay?
A. A = A₀e^(+λt)
B. A = A₀ − λt
C. A = A₀e^(−λt)
D. A = A₀/λt
Answer: C. A = A₀e^(−λt)
Rationale: Radioactive decay follows an exponential relationship. In
the equation A = A₀e^(−λt), A is the remaining activity, A₀ is the initial
activity, λ is the decay constant, and t is elapsed time. The half-life is
related to the decay constant by t½ = ln(2)/λ.
2
,4. A nuclear pharmacist notices that a radiopharmaceutical
preparation has a radiochemical purity substantially below the
manufacturer's specified acceptance range. What is the most
appropriate action?
A. Dispense it because the radionuclide is correct
B. Increase the administered dose to compensate
C. Investigate the cause and quarantine the preparation until suitability is
established
D. Add another radiopharmaceutical to restore purity
Answer: C. Investigate the cause and quarantine the preparation
until suitability is established
Rationale: Radiochemical impurities can alter biodistribution and
reduce diagnostic accuracy or therapeutic effectiveness. A preparation
failing established quality specifications should not simply be
dispensed or compensated for by changing the dose. It should be
quarantined and investigated according to established quality-
assurance procedures.
5. Which property is most important when selecting shielding for a
high-energy gamma-emitting radionuclide?
A. The color of the container
B. Photon energy and attenuation characteristics of the shielding
material
C. The patient's body weight
D. The chemical pH of the radiopharmaceutical
Answer: B. Photon energy and attenuation characteristics of the
shielding material
Rationale: Shielding effectiveness depends strongly on radiation type
and energy, material density, thickness, and geometry. High-energy
3
, photons may require substantial quantities of dense shielding material.
The choice should be based on the radiation characteristics and
applicable radiation-safety requirements rather than cosmetic or
pharmaceutical properties.
6. The three fundamental principles of occupational radiation
protection are best represented by:
A. Sterility, potency, and stability
B. Time, distance, and shielding
C. Dose, volume, and concentration
D. Absorption, distribution, and elimination
Answer: B. Time, distance, and shielding
Rationale: Minimizing exposure involves reducing the time spent near
radiation sources, maximizing distance from the source whenever
practical, and using appropriate shielding. These principles form the
foundation of occupational radiation protection.
7. Why does increasing distance from a point-like radiation source
substantially reduce exposure?
A. Radioactivity disappears with distance
B. Radiation follows the inverse-square relationship under appropriate
geometric conditions
C. Distance chemically neutralizes radionuclides
D. Distance increases the physical half-life
Answer: B. Radiation follows the inverse-square relationship under
appropriate geometric conditions
Rationale: For a point source in free space, radiation intensity
approximately follows the inverse-square law. Doubling the distance
4
PHARMACIST CERTIFICATION EXAM WITH
ACTUAL QUESTIONS AND VERIFIED
ANSWERS, PLUS EXPLAINED
RATIONALES/EXPERT VERIFIED FOR
GUARANTEED 100% PASS 2026/LATEST
UPDATE/INSTANT DOWNLOAD PDF
1. A nuclear pharmacist is preparing a patient-specific unit dose of a
radiopharmaceutical. Which characteristic most directly
distinguishes nuclear pharmacy practice from conventional
pharmacy practice?
A. All medications must be administered intravenously
B. Radiopharmaceuticals require consideration of radioactive decay,
radiation exposure, and radiochemical purity in addition to conventional
medication-related concerns
C. Nuclear pharmacists do not need to verify medication identity
D. Radiopharmaceuticals are exempt from quality-control procedures
Answer: B. Radiopharmaceuticals require consideration of
radioactive decay, radiation exposure, and radiochemical purity in
addition to conventional medication-related concerns
Rationale: Nuclear pharmacy requires the pharmacist to integrate
conventional pharmaceutical principles with radiation safety,
radionuclide identity, physical decay, radiochemical purity, chemical
purity, sterility when applicable, and appropriate handling and
dispensing procedures. The radioactive nature of the product
introduces time-dependent changes and occupational exposure
considerations that do not generally apply to conventional
medications.
1
,2. A technetium-99m preparation has a physical half-life of
approximately 6 hours. If a sample initially contains 80 mCi,
approximately how much activity remains after 18 hours, assuming
no biological elimination?
A. 40 mCi
B. 20 mCi
C. 10 mCi
D. 5 mCi
Answer: C. 10 mCi
Rationale: Eighteen hours represents three physical half-lives. After
one half-life, 80 mCi becomes 40 mCi; after two, 20 mCi; after three,
10 mCi. Thus, the remaining activity is approximately 10 mCi. This
calculation is fundamental when determining expected activity at a
future administration time.
3. Which equation most accurately describes radioactive decay?
A. A = A₀e^(+λt)
B. A = A₀ − λt
C. A = A₀e^(−λt)
D. A = A₀/λt
Answer: C. A = A₀e^(−λt)
Rationale: Radioactive decay follows an exponential relationship. In
the equation A = A₀e^(−λt), A is the remaining activity, A₀ is the initial
activity, λ is the decay constant, and t is elapsed time. The half-life is
related to the decay constant by t½ = ln(2)/λ.
2
,4. A nuclear pharmacist notices that a radiopharmaceutical
preparation has a radiochemical purity substantially below the
manufacturer's specified acceptance range. What is the most
appropriate action?
A. Dispense it because the radionuclide is correct
B. Increase the administered dose to compensate
C. Investigate the cause and quarantine the preparation until suitability is
established
D. Add another radiopharmaceutical to restore purity
Answer: C. Investigate the cause and quarantine the preparation
until suitability is established
Rationale: Radiochemical impurities can alter biodistribution and
reduce diagnostic accuracy or therapeutic effectiveness. A preparation
failing established quality specifications should not simply be
dispensed or compensated for by changing the dose. It should be
quarantined and investigated according to established quality-
assurance procedures.
5. Which property is most important when selecting shielding for a
high-energy gamma-emitting radionuclide?
A. The color of the container
B. Photon energy and attenuation characteristics of the shielding
material
C. The patient's body weight
D. The chemical pH of the radiopharmaceutical
Answer: B. Photon energy and attenuation characteristics of the
shielding material
Rationale: Shielding effectiveness depends strongly on radiation type
and energy, material density, thickness, and geometry. High-energy
3
, photons may require substantial quantities of dense shielding material.
The choice should be based on the radiation characteristics and
applicable radiation-safety requirements rather than cosmetic or
pharmaceutical properties.
6. The three fundamental principles of occupational radiation
protection are best represented by:
A. Sterility, potency, and stability
B. Time, distance, and shielding
C. Dose, volume, and concentration
D. Absorption, distribution, and elimination
Answer: B. Time, distance, and shielding
Rationale: Minimizing exposure involves reducing the time spent near
radiation sources, maximizing distance from the source whenever
practical, and using appropriate shielding. These principles form the
foundation of occupational radiation protection.
7. Why does increasing distance from a point-like radiation source
substantially reduce exposure?
A. Radioactivity disappears with distance
B. Radiation follows the inverse-square relationship under appropriate
geometric conditions
C. Distance chemically neutralizes radionuclides
D. Distance increases the physical half-life
Answer: B. Radiation follows the inverse-square relationship under
appropriate geometric conditions
Rationale: For a point source in free space, radiation intensity
approximately follows the inverse-square law. Doubling the distance
4
